Leuprorelin Acetate SR 11.25 mg for Injection
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Leuprorelin Acetate SR 11.25 mg for Injection, covering 2016-02-17 to 2016-02-17. Get the full timeline:
Most recent: Clinical Trial Update: Leuprorelin Acetate SR 11.25 mg for Injection Specified Drug-use Survey "Long-term Use Survey on Premenopausal Breast Cancer Patients (96 Weeks)"